The global market size for hyaluronic acid-based dermal fillers is estimated to be growing at a CAGR of 8.14% from 2023 to 2028. The market was valued at USD 4.65 billion in 2023 and is forecasted to value at USD 6.87 billion by 2028.
Hyaluronic Acid is a naturally occurring chemical found in our skin, eyes, and joints. Its principal role is to keep skin moist by trapping water inside the tissue. Dermal fillers are a type of soft gel that is injected beneath the skin. Hyaluronic acid dermal fillers are gaining popularity among patients and dermatologists alike. Scars, acne, and wrinkles are treated with them and chin, cheek, and lip augmentation. Hyaluronic acid fillers can stimulate, volumize, and moisturize the skin and stimulate new collagen formation, and smooth fine creases on the face. Hyaluronic acid fillers are preferred by consumers over other injectables for aesthetic and cosmetic treatments because they have fewer unfavorable side effects and stay longer. Dermal fillers based on hyaluronic acid, also known as hyaluronan, are made from a clear material produced naturally in the human body.
Impact of COVID-19 on the global hyaluronic acid-based dermal fillers market:
The ongoing vaccination effort for new coronavirus (COVID-19) control gives public health officials a chance to get out of the current pandemic catastrophe. The covid-19 vaccine, which protects against the disease, can cause minor side effects and, in rare situations, severe or rapid reactions. Because the surgery is considered elective, it was one of the first medical operations to suffer cancellations, and the market has been hit particularly hard. To prevent the spread of the infection, numerous countries affected by the outbreak have delayed elective and non-essential surgeries. In addition, the medical cosmetics sectors have seen supply chain delays due to the COVID-19-imposed lockdowns, which include restrictions on import and export, flight cancellations, reduced output, and disrupted supply lines. As a result of the decreased demand, it had a detrimental impact on injectable filler sales worldwide. As a result, the market had negative growth during the pandemic and grew after the minimum of Covid-19.
The need for youthful, flawless skin using outpatient and non-invasive aesthetic dermatology procedures is expected to drive the worldwide hyaluronic acid-based dermal fillers market.
Furthermore, the market is likely to gain from an increase in medical tourism for various aesthetic procedures. Over the forecast period, increased demand for minimally invasive facial treatments and the adaption of hyaluronic acid-based cosmetic products are expected to drive market expansion. Furthermore, an aging population and developments in hyaluronic acid-based surgical procedures, such as using ultrasound to improve treatment efficiency, are expected to drive product adoption. The expansion of the market can be linked to factors such as the reduced risk of side effects, less painful procedures with more minor scars, and low skin scratches. The improved safety features of HA-based dermal treatments and the relative endurance of HA-based dermal fillers are also driving demand in the global market.
The global market for hyaluronic acid-based dermal fillers has grown dramatically in the last few years. One of the key reasons for this is the growing concern among men and women about preserving beauty standards. People opt for therapy to smooth the skin texture or repair wrinkles, augment lips, and other cosmetic treatments to improve their physical appearance because of the ever-changing beauty standards. Increased R&D investment by big companies in the market for new dermal product inventions contributes to the worldwide market's growth. However, as individuals become more aware of the treatment and want to look younger, the global hyaluronic acid-based dermal fillers market is expected to increase rapidly.
The high cost of dermal filling treatments may stifle the global market for hyaluronic acid-based dermal fillers. The market's expansion is hampered by adverse effects such as the black market for dermal fillers and unregistered practitioners.
This research report on the global hyaluronic acid-based dermal fillers market has been segmented and sub-segmented based on product, application, end-user & region.
Hyaluronic Acid-based Dermal Fillers Market – By Product:
Dermatologists and customers favor single-phase products to treat soft tissue facial abnormalities because the uncross-linked HA promotes elastin and collagen production, giving the face a youthful and healthy-looking shine. In addition, the single-phase product is not subjected to the sizing technique, which breaks down the gel throughout production. In producing single-phase dermal fillers like Juvederm Ultra, Hylacross technology is used, resulting in product life and desirable effects.
Hyaluronic Acid-based Dermal Fillers Market – By Application:
Based on the application, the wrinkle removal treatment application is predicted to have a sizable market share during the forecast period. Due to rising customer awareness and an aging population worldwide, wrinkle treatment is expected to have a considerable market in the application area. Furthermore, developments in hyaluronic acid-based dermal filler technologies for wrinkle treatment and rising spending on cosmetic operations are likely to drive market growth throughout the projection period.
Hyaluronic Acid-based Dermal Fillers Market – By End-User:
Based on the end-user, the specialty dermatology clinics segment accounted for the largest share in 2022. The global market is predicted to be propelled by establishing and developing an adolescent and young adult dermatology clinic with an embedded expert. The presence of varied specialists serving patients of all ages and statistically significant improvements in quality of life help improve the outcome of therapy.
Hyaluronic Acid-based Dermal Fillers Market – By Region:
Because of the increasing demand for cosmetic and aesthetic products in countries like Japan, China, South Korea, Thailand, and India, the Asia Pacific region will develop the fastest in the next few years. During the forecast period, the hyaluronic acid-based dermal fillers market will be fueled by increased awareness of hyaluronic acid-based dermal fillers and increased demand for aesthetics in growing nations such as India and China. Due to the availability of advanced hyaluronic acid-based dermal fillers and the high proportion of the elderly population in Japan, there is a significant demand for these dermal fillers. This demand is predicted to rise as social media's influence grows and people become more aware of minimally invasive procedures for cosmetic and aesthetic medical treatments. Furthermore, the cheaper cost of these products is projected to boost the regional market.
Factors such as a rapidly aging population and increased public knowledge of advanced aesthetic procedures drive the European market. Another factor driving the usage of dermal fillers in the region is an increase in per capita income in countries like Spain.
Because of its well-established healthcare infrastructure, favorable policies, and growing number of plastic surgery treatments, North America is expected to have a considerable market share. The increasing demand for advanced hyaluronic acid-based dermal fillers with an improved safety profile, which results in significantly fewer adverse responses, is projected to drive growth in the region.
Due to the significant number of hyaluronic acid-based dermal filler operations performed in Brazil, it is one of the leading markets in Latin America.
KEY MARKET PARTICIPANTS:
Galderma Laboratories, Sinclair Pharma, Bioplus Co., Ltd., Merz Pharma, Allergan, Bioxis Pharmaceuticals, Sculpt Luxury Dermal Fillers Ltd, Dr. Korman, Prollenium Medical Technologies, Candela Corporation, Suneva Medical, Anika Therapeutics, Inc., Genzyme Corporation, LG Life Sciences, Ltd. (LG Chem.) and Laboratoires Vivacy are a few of the notable companies operating in the global hyaluronic acid-based dermal fillers market profiled in this report.
RECENT HAPPENINGS IN THIS MARKET:
The global hyaluronic acid-based dermal fillers market size was valued at USD 3.98 billion in 2021.
Geographically, the North American region is projected to be dominant in the global hyaluronic acid-based dermal fillers market during the forecast period.
The APAC hyaluronic acid-based dermal fillers market is anticipated to grow at a CAGR of 10.10% from 2022 to 2027.
Companies playing a notable role in the market are Galderma Laboratories, Sinclair Pharma, Bioplus Co., Ltd., Merz Pharma, Allergan, Bioxis Pharmaceuticals, Sculpt Luxury Dermal Fillers Ltd, Dr. Korman, Prollenium Medical Technologies, Candela Corporation, Suneva Medical, Anika Therapeutics, Inc., Genzyme Corporation, LG Life Sciences, Ltd. (LG Chem.) and Laboratoires Vivacy.
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2500
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: email@example.com